Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92


Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.

Warren BB, Jacobson L, Kempton C, Buchanan GR, Recht M, Brown D, Leissinger C, Shapiro AD, Abshire TC, Manco-Johnson MJ; Joint Outcome Study Group Investigators.

Haemophilia. 2019 May 21. doi: 10.1111/hae.13778. [Epub ahead of print]


The effect of psychological distress on health outcomes: A systematic review and meta-analysis of prospective studies.

Barry V, Stout ME, Lynch ME, Mattis S, Tran DQ, Antun A, Ribeiro MJ, Stein SF, Kempton CL.

J Health Psychol. 2019 Apr 11:1359105319842931. doi: 10.1177/1359105319842931. [Epub ahead of print]


Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

Kruse-Jarres R, Oldenburg J, Santagostino E, Shima M, Kempton CL, Kessler CM, Lehle M, Chebon S, Selak Bienz N, Asikanius E, Mahlangu J.

Haemophilia. 2019 Mar;25(2):213-220. doi: 10.1111/hae.13655. Epub 2019 Feb 6.


Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.

Weitzmann MN, Roser-Page S, Vikulina T, Weiss D, Hao L, Baldwin WH, Yu K, Del Mazo Arbona N, McGee-Lawrence ME, Meeks SL, Kempton CL.

Blood Adv. 2019 Feb 12;3(3):288-300. doi: 10.1182/bloodadvances.2018027557.


Evaluation of Treatment-Dose Enoxaparin in Acutely Ill Morbidly Obese Patients at an Academic Medical Center: A Randomized Clinical Trial.

Curry MA, LaFollette JA, Alexander BR, Evans KS, Tran RH, Kempton CL.

Ann Pharmacother. 2019 Jun;53(6):567-573. doi: 10.1177/1060028018821149. Epub 2018 Dec 21.


Vestibular Testing: Patient Perceptions, Morbidity, and Opportunity Costs.

Kelly EA, Stocker C, Kempton CM, Dierking DM, Fehlberg HE, Adams ME.

Otol Neurotol. 2018 Dec;39(10):1222-1228. doi: 10.1097/MAO.0000000000002025.


Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.

Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME, Schmitt C, Jiménez-Yuste V, Kempton C, Dhalluin C, Callaghan MU, Bujan W, Shima M, Adamkewicz JI, Asikanius E, Levy GG, Kruse-Jarres R.

N Engl J Med. 2018 Aug 30;379(9):811-822. doi: 10.1056/NEJMoa1803550.


HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.

Kempton CL, Payne AB.

Blood Adv. 2018 Jul 24;2(14):1750-1755. doi: 10.1182/bloodadvances.2018019323.


A cross-sectional study of non-attendance among patients at a US hemophilia treatment center 2010-2014.

Barry V, Steffens C, Mattis S, Sidonio RF Jr, Tran DQ, Kempton CL.

Haemophilia. 2018 Nov;24(6):902-910. doi: 10.1111/hae.13553. Epub 2018 Jul 10.


A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Sood SL, Cheng D, Ragni M, Kessler CM, Quon D, Shapiro AD, Key NS, Manco-Johnson MJ, Cuker A, Kempton C, Wang TF, Eyster ME, Kuriakose P, von Drygalski A, Gill JC, Wheeler A, Kouides P, Escobar MA, Leissinger C, Galdzicka S, Corson M, Watson C, Konkle BA.

Blood Adv. 2018 Jun 12;2(11):1325-1333. doi: 10.1182/bloodadvances.2018018226.


What can we learn from using formal patient-reported outcome instruments to assess pain, functional impairment, anxiety, and depression in US adults with hemophilia?

Buckner TW, Batt K, Cooper DL, Kempton CL.

Eur J Haematol. 2018 Apr;100 Suppl 1:3-4. doi: 10.1111/ejh.13026.


Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.

Buckner TW, Batt K, Quon D, Witkop M, Recht M, Kessler C, Baumann K, Hernandez G, Wang M, Cooper DL, Kempton CL.

Eur J Haematol. 2018 Apr;100 Suppl 1:5-13. doi: 10.1111/ejh.13027.


Mitigating the effect of persistent postnatal depression on child outcomes through an intervention to treat depression and improve parenting: a randomised controlled trial.

Stein A, Netsi E, Lawrence PJ, Granger C, Kempton C, Craske MG, Nickless A, Mollison J, Stewart DA, Rapa E, West V, Scerif G, Cooper PJ, Murray L.

Lancet Psychiatry. 2018 Feb;5(2):134-144. doi: 10.1016/S2215-0366(18)30006-3.


Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.

Kempton CL, Recht M, Neff A, Wang M, Buckner TW, Soni A, Quon D, Witkop M, Boggio L, Gut RZ, Cooper DL.

Haemophilia. 2018 Mar;24(2):261-270. doi: 10.1111/hae.13377. Epub 2017 Dec 8.


Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.

Buckner TW, Wang M, Cooper DL, Iyer NN, Kempton CL.

Patient Prefer Adherence. 2017 Oct 11;11:1745-1753. doi: 10.2147/PPA.S141392. eCollection 2017.


Current and emerging factor VIII replacement products for hemophilia A.

Cafuir LA, Kempton CL.

Ther Adv Hematol. 2017 Oct;8(10):303-313. doi: 10.1177/2040620717721458. Epub 2017 Aug 26. Review.


Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study.

Kempton CL, Wang M, Recht M, Neff A, Shapiro AD, Soni A, Kulkarni R, Buckner TW, Batt K, Iyer NN, Cooper DL.

Patient Prefer Adherence. 2017 Sep 19;11:1603-1612. doi: 10.2147/PPA.S141389. eCollection 2017.


Method to Increase Undergraduate Laboratory Student Confidence in Performing Independent Research.

Kempton CE, Weber KS, Johnson SM.

J Microbiol Biol Educ. 2017 Apr 21;18(1). pii: 18.1.18. doi: 10.1128/jmbe.v18i1.1230. eCollection 2017. No abstract available.

Supplemental Content

Loading ...
Support Center